T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

S Stemme, B Faber, J Holm, O Wiklund, J L Witztum, G K Hansson, S Stemme, B Faber, J Holm, O Wiklund, J L Witztum, G K Hansson

Abstract

Atherosclerosis, an underlying cause of myocardial infarction, stroke, and other cardiovascular diseases, consists of focal plaques characterized by cholesterol deposition, fibrosis, and inflammation. The presence of activated T lymphocytes and macrophages and high expression of HLA class II molecules are indicative of a local immunologic activation in the atherosclerotic plaque, but the antigen(s) involved has not yet been identified. We established T-cell clones from human atherosclerotic plaques using polyclonal mitogens as stimuli and exposed the clones to potential antigens in the presence of autologous monocytes as antigen-presenting cells. Four of the 27 CD4+ clones responded to oxidized low density lipoprotein (oxLDL) by proliferation and cytokine secretion; this response was dependent on autologous antigen-presenting cells and restricted by HLA-DR. All clones that responded to oxLDL secreted interferon gamma upon activation, but only one produced interleukin 4, suggesting that the response to oxLDL results in immune activation and inflammation but may not be a strong stimulus to antibody production. No significant response to oxLDL could be detected in CD4+ T-cell clones derived from the peripheral blood of the same individuals. Together, the present data suggest that the inflammatory infiltrate in the atherosclerotic plaque is involved in a T-cell-dependent, autoimmune response to oxLDL.

References

    1. J Exp Med. 1989 Nov 1;170(5):1595-608
    1. J Clin Invest. 1989 Oct;84(4):1086-95
    1. J Exp Med. 1990 Mar 1;171(3):801-17
    1. Arteriosclerosis. 1990 May-Jun;10(3):325-35
    1. Arteriosclerosis. 1990 May-Jun;10(3):336-49
    1. J Biol Chem. 1990 Jul 15;265(20):11751-60
    1. J Exp Med. 1991 Jan 1;173(1):25-36
    1. Lab Invest. 1991 Jan;64(1):5-15
    1. Science. 1991 Feb 15;251(4995):788-91
    1. J Lipid Res. 1991 Dec;32(12):1983-91
    1. Circ Res. 1992 Nov;71(5):1268-76
    1. Br Heart J. 1993 Jan;69(1 Suppl):S38-41
    1. Nature. 1993 Apr 29;362(6423):801-9
    1. J Clin Invest. 1993 Aug;92(2):1004-8
    1. Arterioscler Thromb. 1994 Jan;14(1):32-40
    1. Arterioscler Thromb. 1994 Apr;14(4):605-16
    1. J Clin Invest. 1955 Sep;34(9):1345-53
    1. Am J Pathol. 1991 Apr;138(4):951-60
    1. Arterioscler Thromb. 1991 Sep-Oct;11(5):1223-30
    1. Lab Invest. 1991 Dec;65(6):654-60
    1. Arterioscler Thromb. 1992 Feb;12(2):206-11
    1. J Clin Invest. 1992 Apr;89(4):1322-30
    1. Lancet. 1992 Apr 11;339(8798):883-7
    1. Arterioscler Thromb. 1992 Apr;12(4):461-7
    1. Anal Biochem. 1976 May 7;72:248-54
    1. Cell. 1977 Nov;12(3):663-73
    1. J Immunol. 1980 Jul;125(1):293-9
    1. Annu Rev Biochem. 1983;52:223-61
    1. Proc Natl Acad Sci U S A. 1984 Jun;81(12):3883-7
    1. J Clin Invest. 1985 Jul;76(1):125-31
    1. J Immunol Methods. 1985 Nov 28;84(1-2):359-64
    1. Arteriosclerosis. 1986 Mar-Apr;6(2):131-8
    1. Clin Exp Immunol. 1986 May;64(2):261-8
    1. J Biol Chem. 1987 Mar 15;262(8):3603-8
    1. Arteriosclerosis. 1987 Mar-Apr;7(2):135-43
    1. J Lipid Res. 1987 Sep;28(9):1110-7
    1. Am J Pathol. 1988 Feb;130(2):369-76
    1. Circ Res. 1988 Oct;63(4):712-9
    1. J Exp Med. 1988 Sep 1;168(3):1041-59
    1. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1372-6
    1. N Engl J Med. 1989 Apr 6;320(14):915-24
    1. Annu Rev Immunol. 1989;7:145-73
    1. Arteriosclerosis. 1989 Jul-Aug;9(4):538-49
    1. Immunol Today. 1989 Feb;10(2):33-5
    1. Lab Invest. 1989 Aug;61(2):166-70
    1. Am J Pathol. 1989 Jul;135(1):169-75
    1. J Cell Sci Suppl. 1988;9:135-49
    1. Am J Cardiol. 1990 Feb 1;65(5):297-302

Source: PubMed

3
Prenumerera